Zentalis Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 5AM VENTURE MANAGEMENT, LLC | 05/15/2026 | 3.95 M | $9.24 M | 0.00% | 5.51% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 2.96 M | $6.92 M | 100.93% | 4.13% |
| ACADIAN ASSET MANAGEMENT LLC | 05/13/2026 | 2.85 M | $6.66 M | -0.04% | 3.97% |
| 05/15/2026 | 2.31 M | $5.41 M | 100.00% | 3.22% | |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 1.94 M | $4.54 M | -32.79% | 2.70% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.73 M | $4.05 M | -11.82% | 2.42% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 1.48 M | $3.47 M | -10.62% | 2.07% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 1.41 M | $3.31 M | 0.84% | 1.97% |
| DECHENG CAPITAL LLC | 05/13/2026 | 1.32 M | $3.10 M | 0.00% | 1.85% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 1.29 M | $3.02 M | 91.62% | 1.80% |
| BLACKROCK, INC. | 05/13/2026 | 1.27 M | $2.97 M | 1.59% | 1.77% |
| 05/15/2026 | 1.23 M | $2.88 M | -6.82% | 1.72% | |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.13 M | $2.65 M | -17.18% | 1.58% |
| PRIMECAP MANAGEMENT CO/CA/ | 05/11/2026 | 957.42 K | $2.24 M | 0.00% | 1.34% |
| PFIZER INC | 05/12/2026 | 953.83 K | $2.00 M | 0.00% | 1.33% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 05/11/2026 | 792.00 K | $1.85 M | 0.63% | 1.11% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 637.12 K | $1.49 M | 3,546.71% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 621.04 K | $1.45 M | 5.42% | 0.87% |
| GSA CAPITAL PARTNERS LLP | 05/08/2026 | 620.41 K | $1.45 M | -46.95% | 0.87% |
| ALMITAS CAPITAL LLC | 05/15/2026 | 610.07 K | $1.43 M | 0.00% | 0.85% |
| BARCLAYS PLC | 05/15/2026 | 591.22 K | $1.38 M | 4.01% | 0.82% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 571.26 K | $1.34 M | 5,423.13% | 0.80% |
| JANE STREET GROUP, LLC | 05/12/2026 | 490.34 K | $1.15 M | 3.63% | 0.68% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 471.44 K | $1.10 M | 12.42% | 0.66% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 462.68 K | $1.08 M | 291.40% | 0.65% |
| 05/15/2026 | 400.00 K | $936.00 K | 100.00% | 0.56% | |
| MARSHALL WACE, LLP | 05/15/2026 | 392.64 K | $918.79 K | 58.46% | 0.55% |
| PEAPOD LANE CAPITAL LLC | 05/04/2026 | 366.87 K | $834.58 K | -18.27% | 0.51% |
| 05/08/2026 | 360.60 K | $843.80 K | 100.00% | 0.50% | |
| MORGAN STANLEY | 05/15/2026 | 350.21 K | $819.48 K | -56.42% | 0.49% |
| XTX TOPCO LTD | 05/15/2026 | 322.51 K | $754.67 K | -44.08% | 0.45% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 304.47 K | $712.46 K | 100.00% | 0.42% |
| CREATIVE PLANNING | 05/12/2026 | 285.00 K | $666.90 K | 9.62% | 0.40% |
| FMR LLC | 05/15/2026 | 283.92 K | $664.37 K | 16.69% | 0.40% |
| 05/15/2026 | 283.76 K | $664.00 K | 100.00% | 0.40% | |
| ANFIELD CAPITAL MANAGEMENT, LLC | 05/12/2026 | 274.52 K | $642.37 K | 13.15% | 0.38% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 272.03 K | $634.30 K | 182.59% | 0.38% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 269.10 K | $629.69 K | -41.97% | 0.38% |
| WOODLINE PARTNERS LP | 05/15/2026 | 266.03 K | $622.52 K | -49.86% | 0.37% |
| STATE STREET CORP | 05/15/2026 | 249.69 K | $584.28 K | -8.13% | 0.35% |
| SEI INVESTMENTS CO | 05/13/2026 | 191.55 K | $448.23 K | 14.63% | 0.27% |
| UBS GROUP AG | 05/05/2026 | 155.70 K | $364.35 K | -76.92% | 0.22% |
| QUARRY LP | 05/15/2026 | 150.00 K | $351.00 K | 13.64% | 0.21% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 144.64 K | $338.45 K | 80.80% | 0.20% |
| PANAGORA ASSET MANAGEMENT INC | 05/14/2026 | 139.69 K | $326.88 K | 61.23% | 0.19% |
| INVESCO LTD. | 05/12/2026 | 125.77 K | $294.30 K | -33.31% | 0.18% |
| NORTHERN TRUST CORP | 05/14/2026 | 118.19 K | $276.56 K | 27.26% | 0.16% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 05/13/2026 | 117.13 K | $274.08 K | 100.00% | 0.16% |
| JPMORGAN CHASE & CO | 05/13/2026 | 113.13 K | $242.09 K | -38.85% | 0.16% |
| BARR E S & CO | 05/13/2026 | 110.00 K | $257.40 K | 91.30% | 0.15% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Zentalis Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Zentalis Pharmaceuticals Inc. The most heavily invested institutionals were:
5AM Venture Management, LLC: 3.95 M
TWO SIGMA INVESTMENTS, LP: 2.96 M
ACADIAN ASSET MANAGEMENT LLC: 2.85 M
RENAISSANCE TECHNOLOGIES LLC: 1.94 M
CITADEL ADVISORS LLC: 1.73 M
D. E. Shaw & Co., Inc.: 1.48 M
56.27% of Zentalis Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 49.65 M shares in the last 24 months. This purchase volume represents approximately $123.13 M in transactions.